<PAGE> 1
UNITED STATES
SECURITIES EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the quarterly period ended March 31, 1999
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
EXCHANGE ACT OF 1934
COMMISSION FILE NUMBER: 1-10787
VETERINARY CENTERS OF AMERICA, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 95-4097995
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
3420 OCEAN PARK BOULEVARD, SUITE 1000
SANTA MONICA, CALIFORNIA 90405
(Address of principal executive offices)
(310) 392-9599
Registrant's telephone number, including area code
NONE
Former name, address and fiscal year, if changed since last report
Check whether the issuer (1) has filed all reports required to be filed
by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for
such shorter period that the registrant was required to file such reports), and
(2) has been subject to such filing requirements for the past 90 days.
YES [X] NO [ ]
State the number of shares outstanding of each of the issuer's class of
common stock as of the latest practicable date: Common Stock, $.001 Par Value
21,556,669 shares as of May 10, 1999.
<PAGE> 2
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
VETERINARY CENTERS OF AMERICA, INC. AND SUBSIDIARIES
CONDENSED, CONSOLIDATED BALANCE SHEETS
AS OF MARCH 31, 1999 AND DECEMBER 31, 1998
(UNAUDITED)
(IN THOUSANDS, EXCEPT PAR VALUE)
<TABLE>
<CAPTION>
March 31, December 31,
1999 1998
--------- ------------
<S> <C> <C>
ASSETS
Current assets:
Cash and equivalents ....................................... $ 15,668 $ 8,977
Marketable securities ...................................... 30,404 33,358
Trade accounts receivable, less allowance for uncollectible
accounts of $6,532 and $6,920 at March 31 and December 31,
respectively ............................................. 13,544 11,436
Inventory, prepaid expenses and other ...................... 8,220 7,897
Deferred income taxes ...................................... 4,111 4,111
Prepaid income taxes ....................................... 1,910 5,040
--------- ---------
Total current assets ................................... 73,857 70,819
Property and equipment, net .................................. 51,138 50,140
Goodwill, net ................................................ 260,203 256,505
Covenants not to compete, net ................................ 4,685 4,722
Notes receivable ............................................. 2,046 2,088
Investment in Veterinary Pet Insurance ....................... 5,000 5,000
Other assets ................................................. 3,660 3,609
--------- ---------
$ 400,589 $ 392,883
========= =========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Current portion of long-term obligations ................... $ 16,669 $ 17,431
Accounts payable ........................................... 7,032 5,208
Other accrued liabilities .................................. 20,681 16,707
--------- ---------
Total current liabilities .............................. 44,382 39,346
Long-term obligations, less current portion .................. 139,956 142,356
Deferred income taxes ........................................ 5,800 5,800
Minority interest ............................................ 2,639 2,696
Commitments and contingencies
Stockholders' equity:
Common stock, par value $0.001 ............................. 20 20
Additional paid-in capital ................................. 204,934 202,850
Notes receivable from stockholders ......................... (626) (617)
Retained earnings .......................................... 7,080 3,380
Other comprehensive income, unrealized loss on investments . (312) (468)
Less cost of common stock held in treasury, 281 and
227 shares at March 31, 1999 and December 31, 1998,
respectively ............................................. (3,284) (2,480)
--------- ---------
Total stockholders' equity ............................. 207,812 202,685
--------- ---------
$ 400,589 $ 392,883
========= =========
</TABLE>
The accompanying notes are an integral part of these
condensed, consolidated balance sheets.
2
<PAGE> 3
VETERINARY CENTERS OF AMERICA, INC. AND SUBSIDIARIES
CONDENSED, CONSOLIDATED STATEMENTS OF INCOME
FOR THE THREE MONTHS ENDED
MARCH 31, 1999 AND 1998
(UNAUDITED)
(IN THOUSANDS)
<TABLE>
<CAPTION>
1999 1998
------- -------
<S> <C> <C>
Revenues ..................................................... $73,838 $62,069
Direct costs ................................................. 55,441 47,264
------- -------
Gross profit ............................................... 18,397 14,805
Selling, general and administrative expenses ................. 5,645 4,888
Depreciation and amortization ................................ 3,897 3,136
1996 restructuring plan favorable settlement ................. 320 --
------- -------
Operating income ........................................... 9,175 6,781
Interest income .............................................. 466 712
Interest expense ............................................. 2,655 2,996
------- -------
Income before minority interest and provision for income taxes 6,986 4,497
Minority interest in income of subsidiaries .................. 136 155
------- -------
Income before provision for income taxes ................... 6,850 4,342
Provision for income taxes ................................... 3,150 2,035
------- -------
Net income ................................................. $ 3,700 $ 2,307
======= =======
Basic earnings per common share .............................. $ 0.18 $ 0.11
======= =======
Diluted earnings per common share ............................ $ 0.17 $ 0.11
======= =======
Shares used for computing basic earnings per share ......... 20,657 20,205
======= =======
Shares used for computing diluted earnings per share ....... 22,065 21,402
======= =======
</TABLE>
The accompanying notes are an integral part of these
condensed, consolidated financial statements.
3
<PAGE> 4
VETERINARY CENTERS OF AMERICA, INC. AND SUBSIDIARIES
CONDENSED, CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED
MARCH 31, 1999 AND 1998
(UNAUDITED)
(IN THOUSANDS)
<TABLE>
<CAPTION>
1999 1998
-------- --------
<S> <C> <C>
Cash flows from operating activities:
Net income ................................................ $ 3,700 $ 2,307
Adjustments to reconcile net income to net cash
provided by operating activities:
Depreciation and amortization ......................... 3,897 3,136
Amortization of debt discount ......................... 55 53
Minority interest in income of subsidiaries ........... 136 155
Distributions to minority interest partners ........... (193) (100)
Provision for uncollectible accounts .................. 811 658
Increase in accounts receivable, net .................. (2,790) (3,829)
Decrease (increase) in inventory, prepaid expenses
and other assets .................................... (350) 156
Decrease in prepaid income taxes ...................... 3,130 1,019
Increase in accounts payable and accrued liabilities .. 6,423 1,606
-------- --------
Net cash provided by operating activities ........... 14,819 5,161
-------- --------
Cash flows from investing activities:
Property and equipment additions ...................... (2,772) (4,186)
Business acquisitions, net of cash acquired ........... (2,920) (11,535)
Proceeds from sales of marketable securities .......... 23,686 23,303
Investments in marketable securities .................. (20,576) --
Proceeds from the sale of equipment ................... 19 --
Investment in Veterinary Pet Insurance ................ -- (4,000)
-------- --------
Net cash provided by (used in) investing activities . (2,563) 3,582
-------- --------
Cash flows from financing activities:
Repayment of long-term obligations .................... (4,946) (5,280)
Payments received on notes receivable ................. 36 35
Proceeds from issuance of common stock under stock
option plans ........................................ 149 213
Payments on guaranteed purchase price contingently
payable in cash or common stock ..................... -- (46)
Purchase of treasury stock ............................ (804) --
-------- --------
Net cash used in financing activities ............... (5,565) (5,078)
-------- --------
Increase in cash and equivalents ............................ 6,691 3,665
Cash and equivalents at beginning of period ................. 8,977 19,882
-------- --------
Cash and equivalents at end of period ....................... $ 15,668 $ 23,547
======== ========
</TABLE>
The accompanying notes are an integral part of these
condensed, consolidated financial statements.
4
<PAGE> 5
VETERINARY CENTERS OF AMERICA, INC. AND SUBSIDIARIES
NOTES TO CONDENSED, CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 1999
(UNAUDITED)
(1) GENERAL
The accompanying unaudited condensed, consolidated financial statements
of Veterinary Centers of America, Inc. and subsidiaries (the "Company" or "VCA")
have been prepared in accordance with generally accepted accounting principles
for interim financial information and in accordance with the rules and
regulations of the United States Securities and Exchange Commission.
Accordingly, they do not include all of the information and footnotes required
by generally accepted accounting principles for complete financial statements as
permitted under applicable rules and regulations. In the opinion of management,
all adjustments considered necessary for a fair presentation have been included.
The results of operations for the three months ended March 31, 1999 and 1998 are
not necessarily indicative of the results to be expected for the full year. For
further information, refer to the consolidated financial statements and
footnotes thereto for the year ended December 31, 1998 included in the Company's
Annual Report on Form 10-K as filed with the Securities and Exchange Commission
on March 31, 1999.
(2) ACQUISITIONS
During the first quarter of 1999, the Company purchased five animal
hospitals, two of which were merged into existing VCA facilities, and one
veterinary diagnostic laboratory for an aggregate consideration (including
acquisition costs) of $5,861,000, consisting of $2,794,000 in cash, $1,802,000
in debt, 70,712 shares of VCA common stock with a market value of $1,075,000 and
the assumption of liabilities totaling $190,000. The $5,861,000 aggregate
purchase price was allocated as follows: $284,000 to tangible assets, $5,319,000
to goodwill and $258,000 to other intangible assets.
(3) VET'S CHOICE JOINT VENTURE
In February 1997, the Company's joint venture, Vet's Choice, was
restructured and management of the joint venture was assumed by the Company's
partner, Heinz Pet Products ("HPP"). Pursuant to a restructuring agreement, the
Company maintains its 50.5% equity interest in Vet's Choice. Profits and losses
are allocated 99.9% to HPP and 0.1% to the Company, and all management control
has been transferred from the Company to HPP. Additionally, the Company agreed
to provide certain consulting and management services for a three-year period
commencing on February 1, 1997, for an aggregate fee of $15.3 million, payable
in semi-annual installments over a five-year period (the "Consulting Fees"). The
Consulting Fees earned in the three months ended March 31, 1999 and 1998, of
$1,275,000 for each quarter, are included in revenues.
(4) RESTRUCTURING RESERVES
During 1996, the Company adopted and implemented a restructuring plan
(the "1996 Plan") designed to restructure the Company's animal hospital and
laboratory operations in connection with its 1996 acquisitions. In addition,
certain hospitals which did not meet the new standards for performance adopted
by the Company in light of the increase in the size of its animal hospital
operations, were to be closed or sold. During the three months ended March 31,
1999, pursuant to the 1996 Plan, the Company incurred $231,000 of cash
expenditures for lease and other contractual obligations. Also, during the three
months ended March 31, 1999, the Company recognized a $320,000 favorable
settlement from a laboratory operations' contract, terminated as part of the
1996 Plan.
At March 31, 1999, the 1996 Plan restructuring reserve balance was
$1,160,000, consisting primarily of lease and other contractual obligations,
which will extend through 2014.
5
<PAGE> 6
During 1997, the Company reviewed the financial performance of its
animal hospitals. As a result of this review, additional animal hospitals were
determined not to meet the Company's performance standards. Accordingly, the
Company adopted phase two of its restructuring plan (the "1997 Plan"). During
the three months ended March 31, 1999, pursuant to the 1997 Plan, the Company
incurred $19,000 of cash expenditures for lease obligations.
At March 31, 1999, the 1997 Plan restructuring reserve balance was
$1,209,000, consisting primarily of lease obligations and reserves for asset
write-downs. The 1997 Plan is expected to be completed in 1999, although certain
lease obligations will continue through 2005.
The following tables summarize the activity in the Company's
restructuring reserves by plan year (in thousands):
The 1996 Plan
<TABLE>
<CAPTION>
Cash Non-Cash
Charges Charges Total
------- -------- -------
<S> <C> <C> <C>
Balance, December 31, 1998 $ 1,391 $ -- $ 1,391
Cash expenditures for lease and other
contractual obligations (231) -- (231)
Refund of disputed contract termination
settlement 320 -- 320
Restructuring plan favorable settlement (320) -- (320)
------- ----- -------
Balance, March 31, 1999 $ 1,160 $ -- $ 1,160
======= ===== =======
</TABLE>
The 1997 Plan
<TABLE>
<CAPTION>
Cash Non-Cash
Charges Charges Total
------- -------- -------
<S> <C> <C> <C>
Balance, December 31, 1998 $ 866 $362 $ 1,228
Cash expenditures for lease and other
contractual obligations (19) -- (19)
----- ---- -------
Balance, March 31, 1999 $ 847 $362 $ 1,209
===== ==== =======
</TABLE>
(5) STOCKHOLDER LAWSUITS
The Company and certain of its current and former officers and directors
were named as defendants in lawsuits filed in both Los Angeles Superior Court
and the United States District Court for the Central District of California,
each entitled Pegasus Holdings and Pacific Strategic Funds Group, Inc. v.
Veterinary Centers of America, Inc., et al., (the "Pegasus Lawsuits") and each
filed on June 19, 1998. The Pegasus Lawsuits primarily involve claims alleging
securities fraud. The Company is unable to assess the likelihood of an adverse
result. There can be no assurances as to the outcome of the Pegasus Lawsuits.
The inability of the Company to resolve the claims that are the basis for the
lawsuits or to prevail in any related litigation could result in the Company
being required to pay substantial monetary damages for which the Company may not
be adequately insured, which could have material adverse effect on the Company's
business, financial position and results of operations. In any event, the
Company's defense of the Pegasus Lawsuits may result in substantial cost to the
Company, as well as significant dedication of management resources, as the
Company intends to vigorously defend against the Pegasus Lawsuits.
(6) RECLASSIFICATIONS
Certain 1998 balances have been reclassified to conform with the 1999
financial statement presentation.
(7) ACCOUNTING PRONOUNCEMENTS
In March 1998, the America Institute of Certified Public Accountants
issued Statement of Position 98-1 "Accounting for the Costs of Computer Software
Developed or Obtained for Internal Use" ("SOP 98-1"), which is effective for
fiscal years beginning after December 15, 1998. The adoption of SOP 98-1 did not
have a material effect on the Company's financial position or its results of
operations.
6
<PAGE> 7
In June 1998, the Financial Accounting Standards Board issued Statement
of Financial Accounting Standards No. 133 "Accounting for Derivative
Instruments and Hedging Activities" ("SFAS 133"), which is effective for all
fiscal quarters of fiscal years beginning after June 15, 1999. SFAS 133
establishes accounting and reporting standards for derivative instruments,
including certain derivative instruments embedded in other contracts,
(collectively referred to as derivatives) and for hedging activities. It
requires that an entity recognize all derivatives as either assets or
liabilities in the statement of financial position and measure those
instruments at fair value. Adoption of SFAS 133 is not expected to have a
material effect on the Company's financial position or results of operations.
(8) CALCULATION OF PER SHARE AMOUNTS
Below is a reconciliation of the income and shares used in the
computations of the basic and diluted earnings per share ("EPS") (amounts in
thousands, except per share amounts):
<TABLE>
<CAPTION>
Three Months Ended Three Months Ended
March 31, 1999 March 31, 1998
---------------------------- ----------------------------
Per Per
Share Share
Income Shares Amount Income Shares Amount
------ ------- ----- ------ ------- -----
<S> <C> <C> <C> <C> <C> <C>
Basic EPS
Net income ................... $3,700 $20,657 $0.18 $2,307 $20,205 $0.11
===== =====
Effect of dilutive securities
Stock options ................ -- 1,408 -- 1,135
Stock guarantees ............. -- -- -- 62
------ ------- ------ -------
Diluted EPS .................... $3,700 $22,065 $0.17 $2,307 $21,402 $0.11
====== ======= ===== ====== ======= =====
</TABLE>
(9) COMPREHENSIVE INCOME
In June 1997, the FASB issued SFAS No. 130, "Reporting Comprehensive
Income" ("SFAS No. 130"), which is effective for the fiscal years beginning
after December 31, 1997. SFAS 130 defines comprehensive income as all changes in
equity during a period except those resulting from investments and/or
distributions to owners. The Company adopted SFAS 130 in 1998, as a result of
certain unrealized holding losses reported in shareholders' equity.
Below is a calculation of comprehensive income (in thousands):
<TABLE>
<CAPTION>
Three Months Ended
March 31,
-------------------
1999 1998
------ ------
<S> <C> <C>
Net income.................................. $3,700 $2,307
Decrease in unrealized loss on investment... 156 --
------ ------
Net comprehensive income.................... $3,856 $2,307
====== ======
</TABLE>
No income tax benefit related to the unrealized loss on investment was
recognized due to potential tax treatment of investment losses.
7
<PAGE> 8
(10) LINES OF BUSINESS
During the three months ended March 31, 1999 and 1998, the Company had
three reportable segments: Animal Hospitals, Laboratories and Corporate. These
segments are strategic business units that have different products, services and
functions. The segments are managed separately because each is a distinct and
different business venture with unique challenges, rewards and risks. The Animal
Hospitals segment provide veterinary services for companion animals and sell
related retail products. The Laboratories segment provide testing services for
veterinarians both associated with the Company and independent of the Company.
Corporate provides selling, general and administrative support for the other
segments. Though Corporate does not generate revenue, it is being included as a
reportable segment to provide a better understanding of the Company as a whole.
The accounting policies of the segments are the same as those described
in the summary of significant accounting policies as detailed in the Company's
1998 10-K filed with the SEC. The Company evaluates performance of segments
based on profit or loss before income taxes, interest income, interest expense
and minority interest, which are evaluated on a consolidated level. For purposes
of reviewing the operating performance of the segments, all inter-segment sales
and purchases are accounted for as if they were transactions with independent
third parties at current market prices.
Below is a summary of certain financial data for each of the three
segments (in thousands):
<TABLE>
<CAPTION>
Inter-Segment
Animal Sales
Hospitals Laboratories Corporate Eliminations Total
--------- ------------ --------- ------------ --------
<S> <C> <C> <C> <C> <C>
THREE MONTHS ENDED MARCH 31, 1999
Revenues.............................. $ 49,726 $ 25,569 $ -- $(1,457) $ 73,838
Operating income (loss)............... 6,340 7,005 (4,170) -- 9,175
Depreciation/amortization expense..... 2,561 1,100 236 -- 3,897
Identifiable assets................... 231,435 108,507 60,647 -- 400,589
Capital expenditures.................. 2,050 630 92 -- 2,772
THREE MONTHS ENDED MARCH 31, 1998
Revenues.............................. $ 44,341 $ 19,102 $ -- $(1,374) $ 62,069
Operating income (loss)............... 6,680 3,877 (3,776) -- 6,781
Depreciation/amortization expense..... 2,036 946 154 -- 3,136
Identifiable assets................... 210,303 112,558 62,994 -- 385,855
Capital expenditures.................. 2,587 1,529 70 -- 4,186
</TABLE>
Corporate operating loss includes salaries, general and administrative
expense for the executive, finance, accounting, human resources, marketing,
purchasing and regional operational management functions that support the Animal
Hospitals and Laboratories segments.
Below is a reconciliation between total segment operating income after
eliminations and consolidated income before provision for income taxes as
reported on the condensed, consolidated statements of operations, (in
thousands):
<TABLE>
<CAPTION>
Three Months Ended
March 31,
1999 1998
------ ------
<S> <C> <C>
Total segment operating income after eliminations.... $9,175 $6,781
Interest income ..................................... 466 712
Interest expense .................................... 2,655 2,996
Minority interest ................................... 136 155
------ ------
Income before provision for income taxes ............ $6,850 $4,342
====== ======
</TABLE>
8
<PAGE> 9
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
Veterinary Centers of America, Inc. and subsidiaries ("VCA" or the
"Company") is one of the nation's largest animal health care companies. The
Company has established a premier position in two core businesses, animal
hospitals ("Animal Hospitals") and veterinary diagnostic laboratories
("Laboratories"). The Company operates the largest nationwide networks of
free-standing, full-service animal hospitals and veterinary-exclusive
laboratories.
Over the past several years, the Company has expanded its animal
hospital network and veterinary diagnostic laboratory operations through
acquisitions. Animal hospitals and veterinary diagnostic laboratories have been
acquired through a combination of issuance of common stock, notes and the
payment of cash.
FUTURE OPERATING RESULTS
This filing contains statements that constitute "forward-looking
statements" within the meaning of the Private Securities Litigation Reform Act
of 1995. The words "expect", "estimate", "anticipate", "predict", "believe" and
similar expressions and variations thereof are intended to identify
forward-looking statements. Such statements appear in a number of places in this
filing and include statements regarding the intent, belief or current
expectations of the Company, its directors or its officers with respect to,
among other things; (i) trends affecting the Company's financial condition or
results of operations, and (ii) the Company's business and growth strategies.
The readers of this filing are cautioned that any such forward-looking
statements are not guarantees of future performance and involve risks and
uncertainties, and that actual results may differ materially from those
projected in this filing, including, without limitation, the information set
forth under the heading "Risk Factors", as well as the information set forth
below.
RESULTS OF OPERATIONS
REVENUES
The following table summarizes the Company's revenues for the three
months ended March 31, 1999 and 1998 (amounts in thousands):
<TABLE>
<CAPTION>
Three Months Ended
March 31,
1999 1998 % Increase
------- ------- ----------
<S> <C> <C> <C>
Animal Hospitals .............. $49,726 $44,341 12.1%
Laboratories .................. 25,569 19,102 33.9%
Intercompany Sales ............ (1,457) (1,374)
------- -------
$73,838 $62,069 19.0%
======= =======
</TABLE>
The increase in Animal Hospitals' revenues in the three months ended
March 31, 1999 from the 1998 comparable period was primarily the result of the
increase in the number of facilities operated by the Company. The results for
1999 include the revenues of 15 animal hospitals acquired subsequent to March
31, 1998. The increase in revenues that resulted from increases in volume or
prices at same-store facilities, as compared to the corresponding period in the
prior-year, was approximately 3.3% for the three months ended March 31, 1999.
Same-store facilities are animal hospitals that were owned as of January 1, 1998
though March 31, 1999.
At March 31, 1999, the Company owned and managed 170 animal hospitals,
of which 24 were located in states that prohibit veterinarians from splitting
fees with non-veterinarians and prohibit business corporations from providing,
or holding themselves out as providers of, veterinary medical care. In these
states the Company has contracted with professional corporations ("PC's") who
provide all medical care and have the rights to all associated revenue. The
Company owns all of the assets of these 24 animal hospitals and provides all
administrative functions. In return for its services,
9
<PAGE> 10
the Company receives management fees from the PC's, which has been included in
the Company's revenues. The Company does not consolidate the operations of these
24 managed animal hospitals, as the Company has not met certain consolidation
requirements. Combined revenues from animal hospitals owned and managed by VCA
(had the managed hospitals' operations been consolidated with the owned
hospitals) increased 12.6% for the first quarter of 1999 relative to the first
quarter of 1998. The increase in combined revenues from animal hospitals owned
and managed by VCA resulting from changes in volume or prices at same-store
facilities, as compared to he corresponding period in the prior-year, was
approximately 3.3% for the three months ended March 31, 1999.
Pursuant to the restructuring agreement and other related agreements
between HPP and the Company, the Company has agreed to provide certain
consulting and management services for a three-year period commencing February
1, 1997 for an aggregate fee of $15.3 million receivable in semi-annual
installments over a five-year period (the "Consulting Fees"). The Consulting
Fees earned in each of the three month periods ended March 31, 1999 and 1998, of
$1,275,000 for each quarter, are included in Animal Hospital revenues.
The increase in Laboratories' revenues was primarily due to the $10.9
million acquisition, on February 26, 1998, of certain assets of the veterinary
diagnostics laboratory business from Laboratory Corporation of America Holdings
("LabCorp"). In addition, Laboratories' revenues have increased as the result of
the acquisition of the business of one other veterinary diagnostic laboratory
since March 31, 1998 and to the success achieved with increased marketing
efforts.
GROSS PROFIT
The following tables summarizes the Company's gross profit for the three
months ended March 31, 1999 and 1998 (amounts in thousands):
<TABLE>
<CAPTION>
Three Months Ended
March 31,
1999 1998 % Increase
------- ------- ----------
<S> <C> <C> <C>
Animal Hospitals ....... $ 8,901 $ 8,716 2.1%
Laboratories ........... 9,496 6,089 56.0%
------- ------- ----
$18,397 $14,805 24.0%
======= =======
</TABLE>
Gross profit for the Animal Hospitals is comprised of revenues less all
costs of services and products at the hospitals, including salaries of
veterinarians, technicians and all other hospital-based personnel, facilities
rent, occupancy costs, medical supply costs and costs of goods sold associated
with the retail sales of pet food and pet supplies. Animal Hospitals' gross
profit represented 17.9% and 19.7% of Animal Hospitals' revenues for the three
months ended March 31, 1999 and 1998, respectively. The decrease in the first
quarter 1999 gross profit margin from first quarter 1998 is the result of lower
than expected revenues due to adverse weather conditions in the Mid-West and
East. The Company continues to take action designed to improve gross margins at
the Animal Hospitals, however, there can be no assurance that in the future the
Company will be successful in its efforts to improve gross profit margins at
these facilities.
The gross profit margin for "same-store" hospitals (those acquired by
VCA prior to January 1, 1998) was 15.8% and 16.5% for the first quarter 1999 and
1998, respectively. The gross profit margin for "newly acquired" hospitals
(those acquired by VCA after January 1, 1998) was 17.1% for the first quarter
1999. Gross profit margins for "same-store" and "newly acquired" hospitals have
been calculated excluding the Consulting Fees of $1,275,000 earned in both 1999
and 1998 first quarters.
Gross profit margins for the combined operations of animal hospitals
owned and managed by VCA was 17.3% and 19.1% for the three months ended March
31, 1999 and 1998, respectively. "Same-store" gross profit margins from combined
operations of animal hospitals owned and managed by VCA was 15.3% and 16.1% for
the first quarter 1999 and 1998, respectively.
10
<PAGE> 11
Gross profit of the Laboratories is comprised of revenues less all
direct costs of services, including salaries of veterinarians, technicians and
other non-administrative, laboratory-based personnel, facilities rent, occupancy
costs, and supply costs. Laboratories gross profit represented 37.1% and 31.9%
of Laboratories revenues for the three months ended March 31, 1999 and 1998,
respectively. The increase in the gross profit percentages for the three months
ended March 31, 1999 when compared to the corresponding 1998 period was
primarily attributable to the phase-in of operations from the acquisition of Lab
Corp. The Company recognized certain costs related to the phase-in of Lab Corp
during the three months ended March 31, 1998, however, revenue generation did
not occur until April 1, 1998.
The Company's Animal Hospitals have historically has realized lower
gross profits margins than that of the Laboratory business. If the portion of
the Company's revenues attributable to its Animal Hospital operations grows in
the future, the historical gross profit margins for the Company as a whole may
not be indicative of those to be expected in the future.
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
VCA Corporate selling, general and administrative expenses consists of
administrative expense, including the salaries of corporate officers, other
professional expenses, rent and occupancy costs associated with the Company's
headquarters.
Selling, general and administrative expense for the three months ended
March 31, 1999 and 1998 is comprised of the following (amounts in thousands):
<TABLE>
<CAPTION>
Three Months Ended
March 31,
1999 1998
------ ------
<S> <C> <C>
VCA Corporate ............... $4,254 $3,622
Laboratories ................ 1,391 1,266
------ ------
$5,645 $4,888
====== ======
</TABLE>
VCA Corporate and Laboratories selling, general and administrative
expense, as a percentage of Animal Hospitals and Laboratories revenues, was 7.5%
and 7.7% for the three months ended March 31, 1999 and 1998, respectively. The
decrease from 1998 to 1999 was primarily attribute to an increase in revenues
without a comparable increase in expenses.
DEPRECIATION AND AMORTIZATION
Depreciation and amortization expense primarily relates to the
depreciation of capital assets and the amortization of excess cost over the fair
value of net assets acquired (goodwill) and certain other intangibles.
Depreciation and amortization expense increased to $3,897,000 for the three
months ended March 31, 1999 from $3,136,000 for the three months ended March 31,
1998. The increase in depreciation and amortization expense is due to the
acquisition of animal hospitals and laboratories since March 31, 1998. The
Company's policy is to amortize goodwill over the expected period to be
benefited, not exceeding forty years.
RESTRUCTURING RESERVES
During 1996, the Company adopted and implemented a restructuring plan
(the "1996 Plan") designed to restructure the Company's animal hospital and
laboratory operations in connection with its 1996 acquisitions. In addition,
certain hospitals which did not meet the new standards for performance adopted
by the Company in light of the increase in the size of its animal hospital
operations, were to be closed or sold. During the three months
11
<PAGE> 12
ended March 31, 1999, pursuant to the 1996 Plan, the Company incurred $231,000
of cash expenditures for lease and other contractual obligations. Also, during
the three months ended March 31, 1999, the Company recognized a $320,000
favorable settlement from a laboratory operations' contract, terminated as part
of the 1996 Plan.
At March 31, 1999, the 1996 Plan restructuring reserve balance was
$1,160,000, consisting primarily of lease and other contractual obligations,
which will extend through 2014.
During 1997, the Company reviewed the financial performance of its
animal hospitals. As a result of this review, additional animal hospitals were
determined not to meet the Company's performance standards. Accordingly, the
Company adopted phase two of its restructuring plan (the "1997 Plan"). During
the three months ended March 31, 1999, pursuant to the 1997 Plan, the Company
incurred $19,000 of cash expenditures for lease obligations.
At March 31, 1999, the 1997 Plan restructuring reserve balance was
$1,209,000, consisting primarily of lease obligations and reserves for asset
write-downs. The 1997 Plan is expected to be completed in 1999, although certain
lease obligations will continue through 2005.
LIQUIDITY AND CAPITAL RESOURCES
Cash provided by operations during the three months ended March 31, 1999
was $14,819,000 compared to $5,161,000 for the comparable period ended March 31,
1998, for an increase of $9,658,000. The most significant component of this
increase relates to the timing of certain receipts and disbursements. Another
factor contributing to the increase in cash provided by operations pertains to
the acquisitions the Company has made since first quarter 1998. The results for
1999 include 15 animal hospitals and two veterinary diagnostic laboratory
businesses acquired since March 31, 1998.
The Company has plans to build, upgrade, expand or replace facilities at
approximately 27 animal hospitals. The Company expended $1.2 million for such
purpose during the three months ended March 31, 1999 and expects to incur
additional costs of approximately $7.7 million over the next 12 months.
Additionally, the Company spent $1.3 million on other equipment and software and
expects to continue upgrades or replacements as needed.
On March 23, 1999, the Company's Board of Directors authorized the
Company to repurchase up to $15 million of its common stock on the open market.
As of May 10, 1999, the Company has acquired 62,000 shares for a total
consideration of $910,444.
On April 1, 1999, the Company consummated a merger agreement with AAH
Management Corp. ("AAH"). As a result, the Company will manage an additional 15
veterinary practices in the New York and New Jersey markets. Under the terms of
the agreement, the Company purchased the stock of AAH for a total consideration
of approximately $12.6 million, consisting of $4.3 million in cash and notes,
and 517,568 shares of VCA common stock valued at approximately $8.3 million. In
addition, the Company assumed AAH debt totaling approximately $15 million.
In 1999, through May 10, the Company has incurred approximately $2.5
million in expenditures relating to Year 2000 compliance, and projects spending
an additional $5.3 million in the remainder of 1999. Of the total $7.8 million
that will be expended, approximately $4.5 million is expected to be capitalized
while $3.3 million is expected to be expensed. See "Impact of Year 2000" for
more information on the Company's plans related to the Year 2000 compliance.
The Company has achieved its growth in the past, and anticipates it will
continue its growth in the future through the acquisition of animal hospitals
for cash, stock, notes and the assumption of liabilities. The Company
anticipates it will complete the acquisition of an additional 15 to 20
individual animal hospitals during the next twelve months, which will require
cash of up to $15 million. In addition, the Company continues to examine
acquisition opportunities in the veterinary diagnostic laboratory field which
may impose additional cash requirements.
The Company intends to fund its future cash requirements primarily from
its cash and marketable securities and funds generated from options. The Company
believes these sources of funds will be sufficient to support the Company's
operations and planned capital expenditures for at least the next 12 months. A
significant portion of the Company's cash requirements is determined by the pace
and size of its acquisitions.
12
<PAGE> 13
IMPACT OF YEAR 2000
GENERAL DESCRIPTION OF THE YEAR 2000 ISSUE
The Year 2000 issue is the result of computer hardware and software
language which utilizes two digits rather than four digits to define the
applicable year. As a result, some of the Company's software, hardware,
equipment and building operating systems have date-sensitive software or
embedded chips which may recognize a date using "00" as Year 1900 rather than as
Year 2000 or not recognize the year at all. This could result in system failures
which would disrupt Company operations, including a temporary inability of the
Company to process transactions and customer invoices or engage in normal
business activities.
The Company will be required to modify or replace significant portions
of its software, hardware, equipment and building operating systems so that
those systems and equipment will properly function beyond December 31, 1999. The
Company presently believes that with modification or replacement of certain
existing software, hardware, equipment and building operating systems, the Year
2000 issue should be mitigated, however, if action is not timely, the Year 2000
issue could have a material impact on the operations of the Company.
STATE OF READINESS
The Company's plan to resolve its Year 2000 issues involves the
following four phases: (i) completing an inventory of all software, hardware,
equipment and building operating systems ("Inventory"); (ii) assessing the Year
2000 compliance status of all software, hardware, equipment and building
operating systems ("Assessment"); (iii) repairing or replacing software,
hardware, equipment and building operating systems that are determined not to be
Year 2000 compliant ("Repair/Replace"); and (iv) testing software, hardware,
equipment and building operating systems for Year 2000 compliance ("Testing").
The Company will assess each of its three divisions of business operations
(Animal Hospitals, Laboratories and VCA Corporate) for Year 2000 compliance.
As of March 31, 1999, the Company has completed its inventory of all
software, hardware, equipment and building operating systems. The Company has
completed its assessment of the IT (Information Technology) systems that could
be significantly affected by the Year 2000 issue. A preliminary assessment of
the non-IT systems and equipment resulted in the determination that the impact
of the Year 2000 issue on such non-IT systems and equipment would not be
material to the Company's overall operations. A final assessment and
determination of non-IT systems and equipment has begun and will be completed in
June 1999. There are no significant IT projects that have currently been
deferred due to the Year 2000 efforts.
13
<PAGE> 14
The Company's Year 2000 compliance plan includes either upgrades to or
replacement of software, hardware, equipment and building operating systems. The
Company's Year 2000 efforts are progressing according to schedule. The status of
the Company's progress, identified by phase and division, is summarized in the
table below:
<TABLE>
<CAPTION>
Estimated
Projected Percentage
Phase Division Start Date Completion Date Complete
- ---------- ---------------- -------------- --------------- ----------
<S> <C> <C> <C> <C>
Inventory Animal Hospitals September 1998 January 1999 100%
VCA Corporate September 1998 January 1999 100%
Laboratories September 1998 January 1999 100%
Assessment Animal Hospitals October 1998 June 1999 80%
VCA Corporate October 1998 March 1999 100%
Laboratories September 1998 April 1999 100%
Repair/Replace Animal Hospitals February 1999 November 1999 20%
VCA Corporate October 1998 August 1999 60%
Laboratories October 1998 October 1999 90%
Testing Animal Hospitals February 1999 November 1999 20%
VCA Corporate October 1998 August 1999 60%
Laboratories October 1998 October 1999 90%
</TABLE>
The Company projects that modifications to all software, hardware,
equipment and building operating systems will be Year 2000 compliant by November
1999. It is expected that this will allow sufficient time for further
modifications, if necessary, prior to the arrival of the Year 2000. There is no
certainty that the schedule will proceed according to plan or that delays will
not occur. Specific factors that might cause such delays include the
availability of personnel and the ability to locate and correct all relevant IT
and non-IT systems and equipment.
The Company has completed the process of contacting material third
parties (suppliers, vendors and subcontractors) to determine the extent to which
the Company may be vulnerable as a result of a failure by any of these third
parties to remedy their own Year 2000 issues. The Company has requested all
material third parties to respond to a questionnaire, which was sent by the
Company, on the status of their Year 2000 compliance, and to provide written
assurance that they will be Year 2000 compliant. As of May 10, 1999, the Company
has received approximately 67% of the required responses from material third
parties. Most of the responses received from third parties indicated that they
are in process of evaluating their Year 2000 compliance. The Company expects to
evaluate and verify the status of all material third-party Year 2000 compliance
status through follow-up questionnaires, letters and phone calls. The Company is
uncertain whether the risks of non-Year 2000 compliance by third parties will
materially affect the Company's operations or financial position. The Company
has determined it is not substantially reliant on any one vendor or supplier and
expects to find alternative resources in order to continue to conduct daily
operations. However, there can be no assurance that material third parties will
not suffer a Year 2000 business disruption which could have a material adverse
effect on the Company's results of operations or financial position.
COSTS TO ADDRESS YEAR 2000 COMPLIANCE
The Company will utilize both internal and external resources to
inventory, assess, repair or replace and test the software, hardware, equipment
and building operating systems needed for Year 2000 modifications. The Company
has prepared a budget relating to all aspects for Year 2000 compliance. This
budget accounts for all labor, hardware, software, maintenance and equipment,
including Animal Hospitals' medical billing systems, VCA Corporate's accounting
system and Laboratories' billing and diagnostic systems.
14
<PAGE> 15
The Company's expenditures in 1999 through May 10, 1999 amounted to
approximately $2.5 million. Expenditures for Year 2000 compliance costs
approximated $365,000 in 1998. The Company projects spending an additional $5.2
million in 1999. The total 1999 budget for the Year 2000 project is estimated at
approximately $7.8 million. There can be no assurance that the actual cost of
Year 2000 correction will not materially exceed these estimates. The projected
costs will be funded through normal operations and leasing of hardware and
software. Additionally, the Company has recently determined that certain
software, hardware, equipment and building operating systems will not have
useful lives beyond 1999 because of Year 2000 system issues. This will result in
shorter useful lives than originally projected. Total depreciation on such
software, hardware, equipment and building operating systems in 1999 is
estimated at $1.6 million, which includes approximately $1 million of additional
accelerated depreciation as a result of the shorter projected useful lives.
RISKS ASSOCIATED WITH YEAR 2000 ISSUES
Unless the Company completes the planned upgrades and implementation of
software, hardware, equipment and building operating systems, the Year 2000
issue will pose significant operational problems. If such conversions are not
made, or are not completed in a timely manner, the Year 2000 issue could have a
material impact on the operations of the Company. Failure to be Year 2000
compliant could result in potential unidentified liabilities, a decline in
billing and collections, and the Company's inability to perform necessary
day-to-day functions. At this time, the estimated lost revenues and the impact
on the Company's operations and financial position cannot be determined. The
following describes the most reasonably likely worst case Year 2000 scenarios
for each division of the Company:
(a) The Company's animal hospitals' medical billing systems would cease
to function properly, resulting in an inability of the Company to
access data or operate the computerized cash balancing features.
Additionally, the medical non-IT systems and equipment would fail,
resulting in an inability of the Company to provide certain
services for clients.
(b) The Company's accounting and payroll systems would fail or
malfunction, resulting in the corruption of data files on a
Company-wide basis. Such failure or malfunction would also prevent
the accounts payable, accounts receivable and payroll functions
from operating properly, resulting in the inability to produce
checks and delays in billings and cash collections.
(c) The Company's laboratories would experience problems if the
computer interface with the lab equipment and/or fax machines fail.
This would prohibit the computerization of lab reports, resulting
in delayed reporting to clients. Certain non-IT medical systems and
equipment also could fail, resulting in an inability of the Company
to provide certain services for customers.
(d) In addition, if any material third parties fail to appropriately
remedy their Year 2000 issues, such failure would have a material
adverse effect on the Company's daily operations, results of
operations and financial position.
CONTINGENCY PLAN
The Company's Year 2000 compliance plan will ultimately include the
development of contingency plans for each division in the event that the Company
has not completed all of its compliance phases in a timely manner or as a result
of any third parties who are unable to provide goods or services essential to
the Company's operations. The Company is in the process of developing the
appropriate contingency plans should it fail to meet its Year 2000 compliance
objectives by December 31, 1999. The Company expects to establish formal
contingency plans for each division by August 1999.
15
<PAGE> 16
RISK FACTORS
WE MAY NOT BE ABLE TO MANAGE OUR GROWTH
Since January 1, 1996, we have experienced rapid growth and expansion.
In 1996, we acquired The Pet Practice Inc. ("Pet Practice"), Pets' Rx, Inc.
("Pets' Rx"), as well as 22 individual animal hospitals and six veterinary
diagnostic laboratories. In 1997, we acquired 15 animal hospitals and three
veterinary diagnostic laboratories. In 1998, we acquired 11 animal hospitals and
one veterinary diagnostic laboratory. As a result of these acquisitions, our
revenues grew from $181.4 million in 1996 to $235.9 million in 1997 to $281.0
million in 1998. In 1999 through March 31, we acquired 5 animal hospitals and
one veterinary diagnostic laboratory. Effective April 1, 1999, the Company
consummated a merger agreement with AAH Management Corp. to acquire 15
veterinary practices in the New York and New Jersey markets.
We have experienced, and will continue to experience, a strain on our
administrative and operating resources. Our growth has also increased the
demands on our information systems and controls. We cannot guarantee that we
will be able to identify, consummate and integrate acquired companies without
substantial delays, costs or other problems. Once integrated, these acquired
companies may not be profitable. In addition, acquisitions involve several other
risks including:
o adverse short-term effects on our reported operating results
o impairments of goodwill and other intangible assets
o the diversion of management's attention
o the dependence on retention, hiring and training of key personnel
o the amortization of intangible assets
o risks associated with unanticipated problems or legal liabilities
Our failure to manage our growth effectively will have a material
adverse effect on our results of operations and our ability to execute our
business strategy.
DEPENDENCE ON ACQUISITIONS FOR GROWTH - IF WE DO NOT ACHIEVE OUR ACQUISITION
PROGRAM STRATEGY OUR GROWTH WILL BE DIMINISHED.
We plan to grow primarily by acquisitions of established animal
hospitals. Our acquisition strategy involves a number of factors which are
difficult to control including:
o the identification of potential acquisition candidates
o the willingness of the owners to sell on reasonable terms
o the satisfactory completion of negotiations
o minimal disruption to our existing operations
Also, our acquisitions may be subject to pre-merger or post-merger
review by governmental authorities for antitrust and other legal compliance. Any
adverse regulatory decision may negatively affect our operations by assessing
fines or penalties or requiring us to divest one or more of our operations.
Our acquisition strategy may cause us to divert our time from operating
matters, which may cause the loss of business and personnel. There are also
possible adverse effects on earnings resulting from the possible loss of
acquired customer bases, amortization of goodwill created in purchase
transactions and the contingent and latent risks associated with the past
operations of, and other unanticipated problems arising in, the acquired
business. If we have sufficient capital, our acquisition strategy involves the
acquisition of at least 15 to 20 facilities per year. Our success is dependent
upon our ability to timely identify, acquire, integrate and manage profitability
of acquired businesses. If we cannot do this, our business and growth may be
harmed.
16
<PAGE> 17
SUBSTANTIAL LEVERAGE - OUR SIGNIFICANT AMOUNT OF INDEBTEDNESS COULD ADVERSELY
AFFECT OUR FINANCIAL HEALTH.
We have a significant amount of indebtedness. We incurred our debt
primarily in connection with the acquisition of our animal hospitals and
veterinary diagnostic laboratories and through the sale of the $84,385,000 of
5.25% convertible debentures in April 1996. In certain instances, the debt we
incur in connection with the acquisition of animal hospitals is secured by the
assets of the acquired hospital. At March 31, 1999, we have consolidated
long-term obligations (including current portion) of $156.6 million and our
ratio of long-term debt (including current portion) to total stockholders'
equity was 75%. We will require substantial capital to finance our anticipated
growth, so we expect to incur additional debt in the future.
WE HAVE RISKS ASSOCIATED WITH OUR INTANGIBLE ASSETS
A substantial portion of our assets consists of intangible assets,
including goodwill and covenants not to compete relating to the acquisition of
animal hospitals and veterinary diagnostic laboratories. At March 31, 1999, our
balance sheet reflected $264.9 million of intangible assets of these types,
which is a substantial portion of our total assets of $400.6 million at that
date. We expect that the aggregate amount of goodwill and other intangible
assets on our balance sheet will increase as a result of future acquisitions. An
increase will have an adverse impact on earnings because goodwill and other
intangible assets will be amortized against earnings. If VCA is sold or
liquidated, we cannot assure you that the value of these intangible assets will
be realized.
We continually evaluate whether events and circumstances have occurred
that suggest that we may not be able to recover the remaining balance of our
intangible assets or that the estimated useful lives of our intangible assets
has changed. If we determine that certain intangible assets have been impaired,
we will reduce the carrying value of those intangible assets, which could have a
material adverse effect on our results of operations during the period in which
we recognize the reduction. Also, if we determine that the estimated useful life
of certain intangible assets has decreased, we will accelerate depreciation or
amortization of that asset, which could have a material adverse effect on our
results of operations.
FLUCTUATIONS IN QUARTERLY RESULTS - OUR OPERATING RESULTS VARY SIGNIFICANTLY
FROM QUARTER TO QUARTER WHICH COULD IMPACT OUR STOCK PRICE.
Our operating results may fluctuate significantly in the future. We
believe that quarter to quarter or annual comparisons of our operating results
are not a good indication of our future performance. Historically, we have
experienced higher sales in the second and third quarters than in the first and
fourth quarters. The demand for our veterinary services is higher during warmer
months because pets spend a greater amount of time outdoors, where they are more
likely to be injured and are more susceptible to disease and parasites. Also,
use of veterinary services may be affected by levels of infestation of fleas,
heartworms and ticks, and the number of daylight hours, as well as general
economic conditions. A substantial portion of our costs are fixed and do not
vary with the level of demand for our services. Therefore, net income for the
second and third quarters at individual animal hospitals and veterinary
diagnostic laboratories generally is higher than in the first and fourth
quarters.
OUR SUCCESS DEPENDS ON KEY MEMBERS OF MANAGEMENT
Our success will continue to depend on our executive officers and other
key management personnel, particularly our Chief Executive Officer, Robert L.
Antin. VCA has employment contracts with Mr. Robert Antin, Mr. Arthur Antin,
Chief Operating Officer and Mr. Neil Tauber, Senior Vice President. Each of
these agreements terminates in January 2002. VCA has no other employment
contracts with its officers. None of VCA's officers is a party to
non-competition covenants which extend beyond the term of their employment with
VCA. VCA does not maintain any key man life insurance coverage on the lives of
its senior management. As we continue to grow, we will continue to hire, appoint
or otherwise change senior managers and other key executives. We cannot assure
you that we will be able to retain our executive officers and key personnel or
attract additional qualified members to management in the future. Also, the
success of certain of our acquisitions may depend on our ability to retain
selling veterinarians of the acquired companies. If we lose the services of any
key manager or selling veterinarian, our business may be materially adversely
affected.
17
<PAGE> 18
COMPETITION
The animal health care industry is highly competitive. We believe that
the primary competitive factors in connection with animal hospitals include:
o convenient location
o recommendation of friends
o reasonable fees
o quality of care
o convenient hours
Our primary competitors for our animal hospitals in most markets are
individual practitioners or small, regional multi-clinic practices. Also,
regional pet care companies and certain national companies, including operators
of super-stores, are developing multi-regional networks of animal hospitals in
markets in which we operate. We believe that the primary competitive factors in
connection with veterinary diagnostic laboratories include:
o quality
o price
o time required to report results
There are many clinical laboratory companies which provide a broad range
of laboratory testing services in the same markets we service. Also, several
national companies provide on-site diagnostic equipment that allows
veterinarians to perform their own laboratory tests.
OUR BUSINESS IS SUBJECT TO GOVERNMENT REGULATION
The laws of many states prohibit veterinarians from splitting
fees with non-veterinarians and prohibit business corporations from providing,
or holding themselves out as providers of, veterinary medical care. These laws
vary from state to state and are enforced by the courts and by regulatory
authorities with broad discretion. While we seek to comply with these laws in
each state in which we operate, we cannot assure you that, given varying and
uncertain interpretations of these laws, we are in compliance with these
restrictions in all states. A determination that we violate any applicable
restriction on the practice of veterinary medicine in any state in which we
operate could have a material adverse effect on our operations if we are unable
to restructure our operations to comply with the requirements of those states.
WE ARE SUBJECT TO ANTI-TAKEOVER PROVISIONS
The Board of Directors is authorized to issue up to 2,000,000 shares of
preferred stock. The Board also is authorized to determine the price, rights,
preferences and privileges of those shares without any further vote or action by
the stockholders. The rights of the holders of any preferred stock may adversely
affect the rights of holders of common stock. Our ability to issue preferred
stock gives us flexibility concerning possible acquisitions and financings, but
it could make it more difficult for a third party to acquire a majority of our
outstanding voting stock. In addition, any preferred stock to be issued may have
other rights, including economic rights, senior to the common stock which could
have a material adverse effect on the market value of the common stock.
We are subject to Delaware laws that could have the effect of delaying,
deterring or preventing a change in control of the Company. One of these laws
prohibits us from engaging in a business combination with any interested
stockholder for a period of three years from the date the person became an
interested stockholder, unless some conditions are met. In addition, provisions
of our Certificate of Incorporation and By-laws could have the effect of
discouraging potential takeover attempts or making it more difficult for
stockholders to change management. Also, H.J. Heinz Company has an option to
purchase our interest in the Vet's Choice joint venture if there is a change in
control (as defined in that agreement), which may have the same effect. As a
result,
18
<PAGE> 19
stockholders may not have the opportunity to sell their shares at a substantial
premium over the market price of the shares.
In addition, we have adopted a Stockholder Rights Plan, under which we
distributed a dividend of one right for each outstanding share of our common
stock. These rights will cause substantial dilution to the ownership of a person
or group that attempts to acquire us on terms not approved by our Board of
Directors and may have the effect of deterring hostile takeover attempts.
SHARES ELIGIBLE FOR FUTURE SALE MAY IMPACT OUR STOCK PRICE
Future sales by existing stockholders could adversely affect the
prevailing market price of the common stock. As of May 10, 1999, VCA had
21,556,669 shares of common stock outstanding (including 289,165 shares held in
treasury), most of which are either freely tradable in the public market without
restriction or tradable in accordance with Rule 144 under the Securities Act.
There are also 17,129 shares which VCA is obligated to issue in connection with
the Pets' Rx and Pet Practice mergers and certain acquisitions; 3,757,418 shares
of common stock issuable upon exercise of outstanding stock options; and
2,456,623 shares issuable upon conversion of convertible debentures. Shares may
also be issued under price guarantees delivered in connection with acquisitions.
VOLATILITY OF STOCK PRICE
Historically, our stock price has been volatile. Factors that may have
significant impact on the market price of our stock include:
o variations in quarterly operating results
o litigation involving VCA
o announcements by VCA or its competitors
o general conditions in the animal health care industry
The stock market in recent years has fluctuated in price and volume
significantly. These fluctuations have been unrelated or disproportionate to the
operating performance of publicly traded companies. Our future earnings and
stock price may be subject to significant volatility, particularly on a
quarterly basis. Shortfalls in our revenues or earnings in any given period
relative to the levels expected by securities analysts could immediately,
significantly and adversely affect the trading price of our common stock.
PENDING LITIGATION
The Company and certain of its current and former officers and directors
were named as defendants in lawsuits filed in both Los Angeles Superior Court
and the United States District Court for the Central District of California,
each entitled Pegasus Holdings and Pacific Strategic Funds Group, Inc. v.
Veterinary Centers of America, Inc., et al., each filed on June 19, 1998. These
lawsuits primarily involve claims alleging securities fraud. Since this action
is in its very preliminary stages, we are unable to assess the likelihood of an
adverse result. We cannot assure you regarding the outcome of these lawsuits.
Our inability to resolve the claims that are the basis for the lawsuits or to
prevail in any related litigation could result in our payment of substantial
monetary damages for which we may not be adequately insured, which could have
material adverse effect on our business, financial position and result of
operations. In any event, our defense of these lawsuits may result in
substantial cost to VCA, as well as significant dedication of management
resources, as we intend to vigorously defend against them.
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
For discussion on legal proceedings, see Risk Factors - "Pending
Litigation". In addition to the legal proceedings described herein, the
Company is a party to other litigation which arises in the ordinary
course of its business, none of which is material.
19
<PAGE> 20
ITEM 2. CHANGES IN SECURITIES
None
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
None
ITEM 5. OTHER INFORMATION
None
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits:
Exhibit 27.1 Financial Data Schedule
(b) Reports on Form 8-K:
Current Report on Form 8-K filed March 23, 1999
Current Report on Form 8-K filed February 18, 1999
20
<PAGE> 21
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
VETERINARY CENTERS OF AMERICA, INC
Date: May 10, 1999 /s/ Tomas W. Fuller
------------------------------------
Tomas W. Fuller
Chief Financial Officer
21
<PAGE> 22
EXHIBIT INDEX
<TABLE>
<CAPTION>
ITEM EXHIBIT PAGE
- ---- ------- ----
<S> <C> <C>
27.1 Financial Data Schedule 23
</TABLE>
22
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
ACCOMPANYING FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-1999
<PERIOD-START> JAN-01-1999
<PERIOD-END> MAR-31-1999
<CASH> 15,668
<SECURITIES> 30,404
<RECEIVABLES> 13,544
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 73,857
<PP&E> 51,138
<DEPRECIATION> 0
<TOTAL-ASSETS> 400,589
<CURRENT-LIABILITIES> 44,382
<BONDS> 0
0
0
<COMMON> 20
<OTHER-SE> 207,812
<TOTAL-LIABILITY-AND-EQUITY> 400,589
<SALES> 0
<TOTAL-REVENUES> 73,838
<CGS> 0
<TOTAL-COSTS> 55,441
<OTHER-EXPENSES> 3,897
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 2,655
<INCOME-PRETAX> 6,850
<INCOME-TAX> 3,150
<INCOME-CONTINUING> 3,700
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 3,700
<EPS-PRIMARY> .18
<EPS-DILUTED> .17
</TABLE>
